EU FMD Serialization Desktop EU FMD Serialization Mobile

EU FMD Serialization: What Every Pharmaceutical Manufacturer Must Know

EU FMD DataMatrix and Anti-Tampering Device on a pharmaceutical carton

The EU Falsified Medicines Directive has been mandatory across Europe since 2019 — and Italy joined in 2025. Here is what your packaging line must do, what your software must handle, and how Jekson delivers it all from one partner.

What Is the EU Falsified Medicines Directive?

The EU Falsified Medicines Directive — formally Directive 2011/62/EU, implemented through Commission Delegated Regulation (EU) 2016/161 — is the European Union's legal framework for preventing counterfeit and falsified medicines from entering the pharmaceutical supply chain. It became mandatory across EU member states on 9 February 2019.

EU FMD requires two physical safety features on every in-scope medicine pack. It also requires that every serialized pack is registered in a digital verification system before it enters distribution, and verified and decommissioned at the point of pharmacy dispensing.

The directive applies to all prescription medicines sold in the EU, plus a defined list of OTC medicines at risk of falsification. It covers Marketing Authorization Holders (MAHs), Contract Manufacturing Organizations (CMOs), parallel distributors, and repackagers — anyone who places or repackages an in-scope medicine for the EU market.

EU FMD applies to you if you:

  • Manufacture or package prescription medicines for the EU market
  • Hold or manufacture under an EU Marketing Authorization
  • Repackage or relabel medicines for parallel trade within the EU
  • Import in-scope medicines into the EU for distribution

The Two Mandatory Safety Features

1

Unique Identifier — the 2D DataMatrix Code

Every in-scope pack must carry a 2D DataMatrix code printed directly on the carton. The code must encode five data elements:

  • Product Code — the GTIN (Global Trade Item Number) in GS1 format
  • Serial Number — a randomized unique number assigned to each individual pack
  • Batch / Lot Number
  • Expiry Date
  • National Product Code — required in certain markets (AIC number for Italy, PC for Greece)

The DataMatrix must meet GS1 print quality Grade C or higher under ISO 15415. It must be readable by high-speed vision inspection cameras on the packaging line and by handheld pharmacy scanners at point of dispense. Failure to meet print quality grade results in verification failure and pack rejection.

2

Anti-Tampering Device — Tamper-Evident Labelling

Every in-scope pack must also carry a physical Anti-Tampering Device (ATD) — in practice a tamper-evident self-adhesive label applied across the carton closure. If the carton is opened, the ATD shows visible evidence of interference that cannot be concealed.

The ATD is a physical hardware requirement. It cannot be satisfied by printing alone — your packaging line needs a label applicator integrated with the serialization system. The applicator must confirm successful label placement before the pack passes downstream. Any pack where the ATD is not applied correctly must be rejected.

This is the requirement that makes Jekson's ST-series machines — the ST200, ST240 and ST250 — the central hardware for EU FMD compliance. They combine DataMatrix printing and inspection with tamper-evident label application and verification in a single integrated machine.

How EU FMD Verification Works: EMVS and NMVS

Printing the DataMatrix and applying the ATD is only the hardware side of EU FMD. The regulation also requires that every serial number is registered in a digital verification system — and verified and decommissioned when the pack is dispensed. This is handled through a two-level architecture.

The EMVS — European Medicines Verification System

The EMVS is the EU-wide hub operated by EMVO (European Medicines Verification Organisation), a not-for-profit entity established by pharma industry stakeholders. The EMVS does not connect directly to manufacturers or pharmacies. It connects the national systems.

The NMVS — National Medicines Verification System

Each EU member state operates its own National Medicines Verification System (NMVS). Manufacturers upload serial numbers to the NMVS for each country where their product will be sold. Pharmacies in that country query the NMVS when dispensing to confirm the pack is genuine and has not already been dispensed.

The Compliance Workflow — Step by Step

StepWhoWhat Happens
1Manufacturer — line levelDataMatrix code printed on carton. ATD applied. Vision system verifies both. Pack passes or is rejected.
2Manufacturer — L4/L5 softwareSerial number commissioned — uploaded to the relevant national NMVS before batch is released from the manufacturing site.
3Wholesaler / distributorPack moves through the supply chain. No verification required at wholesale level under EU FMD, but aggregation data supports logistics.
4Pharmacy — point of dispensePharmacist scans the DataMatrix. Query goes to NMVS. NMVS confirms pack is genuine, active and not previously dispensed.
5Pharmacy — decommissioningNMVS decommissions the serial number. Pack cannot be dispensed again. Any duplicate or already-dispensed pack triggers an alert.

Parallel Trade and Repackaging

Parallel traders who repackage or relabel medicines for a different EU market must decommission the original serial number, repackage, apply a new DataMatrix and ATD, and recommission the new serial number under their own MAH registration before the product can re-enter the supply chain. This is one of the most complex EU FMD scenarios and requires a fully capable L4/L5 system to manage correctly.

Who Must Comply with EU FMD

Organisation TypeEU FMD Obligation
Marketing Authorization Holder (MAH)Responsible for ensuring the pack carries compliant DataMatrix and ATD before release. Must upload serial numbers to the relevant NMVS. Responsible even if manufacturing is outsourced to a CMO.
Contract Manufacturing Organization (CMO)Must apply the DataMatrix and ATD on the line on behalf of the MAH. Must coordinate serial number commissioning with the MAH's L4/L5 system.
Parallel Distributor / RepackagerMust decommission original serial numbers, repackage, apply new DataMatrix and ATD, and recommission under their own authorization before resale in a different EU market.
Importer (non-EU manufacturer)Any manufacturer outside the EU exporting prescription medicines into the EU market must implement EU FMD-compliant serialization on their packaging lines for EU-destined product.
Wholesaler / DistributorMust verify packs show no signs of tampering. Must report suspect packs. Not required to scan and verify serial numbers at wholesale level under current EU FMD — but many trading partners are requiring it contractually.

Country-by-Country Status

EU FMD is a regulation across all 27 EU member states, plus EEA countries (Norway, Iceland, Liechtenstein) which adopted equivalent requirements. Three countries — Italy, Greece and Belgium — were granted a six-year exemption in 2019 due to pre-existing national label systems.

MarketStatus
EU-24 + EEAMANDATORY since 9 February 2019.
BelgiumMANDATORY since 9 February 2019. Belgium implemented on the standard deadline despite having a prior vignette system.
GreeceMANDATORY from 7 February 2025. Hellenic Medicines Verification System (HMVS) became fully operational February 2025.
ItalyDUAL-COMPLIANCE PERIOD: 9 Feb 2025 – 8 Feb 2027. Both Bollini and EU FMD DataMatrix permitted simultaneously. FULL EU FMD ONLY from 9 February 2027.
United KingdomOutside EU FMD post-Brexit. Great Britain follows MHRA requirements. Northern Ireland follows Windsor Framework from January 2025 — 'UK Only' labelling applies, EU FMD disapplied.
Switzerland / Norway / IcelandAdopted equivalent FMD requirements. Connected to EMVS. Treated as EU FMD markets in practice.

Italy: The Bollini Transition

Italy's pre-existing Bollino label system — tamper-evident state-issued stickers applied to every medicine pack since the 1990s — justified Italy's exemption until 2025. The Bollino carries the Italian national product code (AIC number) and functions as both a traceability label and a pharmacy reimbursement document.

From 9 February 2025, Italy entered a two-year stabilization period. Manufacturers supplying Italy must now run both systems in parallel on their lines — applying Bollini, printing and verifying EU FMD DataMatrix codes, applying ATDs, and uploading serial data to the Italian NMVS. From 9 February 2027, only EU FMD serialization is permitted and the Bollini system is discontinued entirely.

Jekson's ST240 and ST250 are specifically built to handle Bollini and Vignette label application and inspection alongside EU FMD DataMatrix serialization — the right machines for Italian market compliance during and after the transition.

For more detail on the Bollini transition, see our European Serialization hub page.

Bollini and EU FMD dual compliance on an Italian packaging line

What Your Packaging Line Needs for EU FMD Compliance

EU FMD compliance requires capability at every level of your operation — hardware on the line, software at site level, and an enterprise platform connecting to the NMVS. Here is the full picture:

LevelRequirementJekson Solution
Line — HardwarePrint GS1 DataMatrix on carton. Apply tamper-evident ATD on both sides of carton closure. Inspect both. Reject non-conforming packs. Handle Bollini/Vignette labels if supplying Italy. ST200 (serialization + ATD)
ST240 (serialization + ATD + Bollini/Vignette)
ST250 (serialization + ATD + Bollini assembly)
Jekson also provides independent Tamper evident system ST100 (if you have pre serialized cartons)
Line — Software (L1–L3)Manage serial number lifecycle from generation to coding and verification. Recipe management for different markets and pack formats. Audit trail for GMP compliance.REETRAK
Aggregation (recommended)Build parent-child hierarchy linking packs to cases and pallets. Generate SSCC shipper labels. Push hierarchy data to enterprise system.TS121 / TS200 / TS201 aggregation stations
Enterprise (L4/L5)Commission serial numbers to national NMVS before batch release. Manage supply chain event reporting. Handle decommissioning and exceptions. ERP/MES integration. Multi-market NMVS management.REESOURCE

The Most Common EU FMD Compliance Gaps

Based on our experience implementing serialization across European pharmaceutical packaging lines, these are the issues that most frequently cause compliance failures or production stoppages:

1

ATD application failure going undetected

The ATD applicator misses a pack or applies the label incorrectly. If the vision system is not configured to verify ATD placement as a hard rejection criterion — not just the DataMatrix code — non-compliant packs pass through to market. EU FMD requires positive verification of both the UI and the ATD.

2

Serial numbers commissioned too late

Manufacturers upload serial numbers to the NMVS after the batch has already left the site. EU FMD requires commissioning before the product is released for distribution. Late commissioning means the packs are technically uncertified at the point they enter the supply chain.

3

Wrong NMVS connection for the target market

A manufacturer uploads serial numbers to the German NMVS for product destined for France. Each EU country has its own NMVS. Your L4/L5 system must upload to the correct national system for every market where the product will be sold. For manufacturers supplying multiple EU countries, this is a data management challenge that requires a capable multi-market enterprise platform.

4

No process for parallel trade repackaging

Parallel traders who repackage medicines for a different EU market have the most complex EU FMD obligation of any supply chain participant. The decommission-repackage-recommission workflow must be fully supported by the L4/L5 system. Many companies discover this gap only when their first repackaged batch cannot be verified at pharmacy.

5

Print quality below Grade C

The DataMatrix code is printed at a quality level that passes the line's own camera but fails at pharmacy dispense scanners. EU FMD requires Grade C or higher under ISO 15415. Line cameras must be calibrated to this standard, not just set to read the code.

6

Italy lines not ready for dual compliance

Manufacturers supplying Italy have until 9 February 2027 to transition fully to EU FMD — but from 9 February 2025 they must be capable of running both Bollini and DataMatrix serialization on the same line simultaneously. Lines that can only do one or the other are out of step with the stabilization period requirements.

How Jekson Vision Delivers EU FMD Compliance

Jekson provides the complete EU FMD solution stack — hardware, line software, enterprise software — all developed in-house and serviced by our own engineering teams in Europe.

On the line

ST-series serialization and tamper-evident machines

Our ST200, ST240 and ST250 machines handle DataMatrix printing and inspection, ATD application and verification, and — for the Italian market — Bollini and Vignette label handling, all in a single integrated machine. They are CE Certified, 21 CFR Part 11 compliant, and powered by REETRAK.

→ See the full solution stack on our European Serialization Solutions page.

Line software

REETRAK (L1–L3)

REETRAK manages serial number generation, DataMatrix encoding with all five EU FMD data elements including country-specific national product codes, label handling, vision inspection logic, and rejection management. It is developed in accordance with GAMP 5 guidelines and supports multi-market recipe management from a single software instance.

Enterprise platform

REESOURCE (L4/L5)

REESOURCE handles NMVS commissioning before batch release, supply chain event reporting, ERP and MES integration, EPCIS event generation, and exception management. For manufacturers supplying multiple EU markets, REESOURCE manages connections to multiple national NMVS systems from a single platform. It integrates with SAP, Oracle and other major ERP systems via REST, SOAP, SFTP and AS2.

Service

24×7 support and engineers in Europe

Our 24×7 helpdesk covers remote diagnostics for both hardware and NMVS connectivity issues. Jekson's own engineering teams, based in Milan and Malta, are available across Europe for on-site installation, commissioning, validation support, and rapid hardware response.

Frequently Asked Questions — EU FMD

EU FMD applies to all prescription medicines sold in the EU, plus a defined list of OTC medicines identified as being at risk of falsification. The list of OTC medicines in scope is set out in Commission Delegated Regulation (EU) 2016/161. Hospital-only medicines have specific dispensing verification rules. Radiopharmaceuticals, investigational medicinal products, and certain other categories carry exemptions — manufacturers should verify the current scope list for their specific product portfolio.

The Unique Identifier (UI) is the 2D DataMatrix code carrying the five data elements — GTIN, serial number, batch number, expiry date and national product code where required. It enables digital verification. The Anti-Tampering Device (ATD) is a physical tamper-evident label applied to the carton closure that provides visible evidence of interference if the pack has been opened. EU FMD requires both. A pack with a correct DataMatrix but no ATD is non-compliant. A pack with an ATD but no DataMatrix is also non-compliant.

Both the MAH and the CMO have obligations. The MAH is ultimately responsible for EU FMD compliance of the finished product. The CMO must be capable of applying the DataMatrix and ATD on the packaging line, and must coordinate serial number management with the MAH's enterprise system. In practice, the CMO's line-level system (L1–L3) must integrate with the MAH's L4/L5 platform for commissioning, or the CMO must operate its own L4 capability on behalf of the MAH. This integration requirement is one of the most common technical challenges in CMO serialization setups.

EU FMD does not legally mandate aggregation — the creation of parent-child hierarchies linking packs to cases and pallets. However, aggregation is increasingly required by wholesalers, logistics partners, and export markets. It also significantly accelerates product recall management. Other global serialization mandates — including DSCSA in the US and CRPT in Russia — do require aggregation. Manufacturers supplying multiple markets will typically need aggregation capability regardless of EU FMD alone.

Yes — if your system is designed for multi-market compliance. The underlying hardware requirements are similar: DataMatrix printing, vision inspection, and tamper-evident label application. The differences are in the software — the data elements encoded, the verification system connections (NMVS for EU FMD, EPCIS for DSCSA), and the aggregation structure. Jekson's REETRAK and REESOURCE are built to handle multiple regulatory frameworks from a single platform, allowing manufacturers to run EU FMD and DSCSA compliance from the same line and enterprise software.

If a pharmacist scans a pack and the serial number is not found in the NMVS, is already decommissioned, or triggers an alert, the pharmacist receives a verification failure notification. The pack must be quarantined and reported as a suspect product. The MAH is notified and must investigate. This process exists to catch counterfeit and falsified medicines — but it also catches legitimate packs where commissioning was performed incorrectly or the DataMatrix was printed at insufficient quality. This is why correct commissioning timing and print quality Grade C or higher are critical operational requirements, not just regulatory formalities.

You need one system capable of managing two separate compliance streams. Great Britain follows MHRA requirements post-Brexit and operates outside the EU's EMVS. Northern Ireland follows the Windsor Framework from January 2025, with EU FMD disapplied and 'UK Only' labelling required. EU-market packs follow full EU FMD including NMVS upload and EMVS connectivity. The pack formats, data elements, and verification systems differ between markets. Jekson's REESOURCE is built to manage multiple market configurations from a single enterprise platform.

You May Also Be Interested In

Ready to Make Your Line EU FMD Compliant?

Whether you are implementing EU FMD for the first time, navigating the Italian Bollini transition, retrofitting a legacy line, or managing compliance across multiple European markets — our team is ready to help.

Whatsapp Logo Tele Logo